Potential of p38 MAP kinase inhibitors in the treatment of cancer-Reference-Cited by-同舟云学术

Potential of p38 MAP kinase inhibitors in the treatment of cancer

Published:2003 Issue: Volume: Page:59-92
ISSN:
Container-title:Progress in Drug Research
language:
Short-container-title:

Author:

Schultz Richard M.

Publisher

Birkhäuser Basel

Link

http://link.springer.com/content/pdf/10.1007/978-3-0348-8012-1_2.pdf

Reference252 articles.

1. F. Balkwill and A. Mantovani: Lancet 357, 539 (2001)

2. R. Virchow, in: A. Hirschwald (ed.): Dreissig Vorlesungen gehalten während des Win-tersemesters 1862–1863 an der Universität zu Berlin. Vorlesungen über Pathologie 3, 2, Berlin (1863)

3. T. Tanaka, H. Kohno, M. Murakami, R. Shimada and S. Kagami: Oncol. Rep. 7, 501 (2000)

4. R.J.H. Collins, M. Feldman and J.S. Fordtran: N. Engl. J. Med.316 1654 (1987)

5. B.I. Korelitz: Am. J. Gastroenterol.78 44 (1983)

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy;Cancers;2024-01-06

2. Lemon Juice Mediated Synthesis of 3-Substituted Quinazolin-4(3H)-Ones and their Pharmacological Evaluation;Anti-Cancer Agents in Medicinal Chemistry;2020-01-23

3. Protein Kinase R Modulates c-Fos and c-Jun Signaling to Promote Proliferation of Hepatocellular Carcinoma with Hepatitis C Virus Infection;PLoS ONE;2013-07-02

4. A Fluorescence-Based Assay for p38α Recruitment Site Binders: Identification of Rooperol as a Novel p38α Kinase Inhibitor;ChemBioChem;2012-12-06

5. Analysis of the role of p38 MAP kinase in epidermal growth factor-induced JB6 Cl41 cell transformation by cDNA array;Gene;2012-04